Skip to content

Clinical trials

Chronic Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chronic Disease Country / region: Italy Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20141
20151
20162
20171
20192
20201
20211
20221
20232
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting7
Active, not recruiting3
Unknown status3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Policlinico San Matteo di Pavia2
Fondazione Salvatore Maugeri2
Meyer Children's Hospital IRCCS2
AusperBio Therapeutics Inc.1
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo1
Azienda Ospedaliero Universitaria Maggiore della Carita1
Fondazione Don Carlo Gnocchi ETS1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
IRCCS San Raffaele1
IRCCS San Raffaele Roma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chronic Disease22
Diabetes Mellitus, Type 23
Cardiovascular Diseases2
Communicable Diseases2
Pulmonary Disease, Chronic Obstructive2
Anxiety Disorders1
Blood-Borne Infections1
Bronchiolitis Obliterans1
Bronchiolitis Obliterans Syndrome1
Chronic Pain1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.